Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
98% of drugs do not reach the brain, as the blood–brain barrier (BBB) separates peripheral blood circulation from the central...
Read moreDetails